Breath based biomarker detection: informing drug development and future treatment regimes

Non-invasive biomarkers are becoming important components of precision medicine-based drug treatment regimes. This article published in Drug Discovery World highlights the shifting focus of precision medicine to a metabolomics approach.

This free download includes information about:

  • The inherent advantages of Breath Biopsy®
  • Use of Volatile Organic Compounds (VOC) biomarkers in translational medicine
  • Exhaled breath analysis in diagnosis & treatment of pulmonary diseases